Testing effectiveness (Phase 2)Study completedNCT07827079
What this trial is testing
Tislelizumab Combined With TAC Regimen as Neoadjuvant Therapy for TNBC
Who this might be right for
Breast Cancer (Triple Negative Breast Cancer (TNBC))Chemeotherapy
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 36